Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

Boehringer Ingelheim5,827 enrolled

Overview

This observational non-interventional study will assess (under conditions of clinical practice in daily routine) the antihypertensive efficacy of telmisartan treatment with or without active promotion of lifestyle changes in hypertensive patients at high cardiovascular risk

Study Design:

Study Type

OBSERVATIONAL

Enrollment

5,827

Conditions

Hypertension Obesity

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: patients with essential hypertension aged \>/= 18 years with one of the following risk factors: history of coronary artery disease or stroke/TIA or peripheral artery disease or diabetes mellitus. Exclusion Criteria: according to SPC

Locations (2389)

Outcomes

Primary Outcomes

Blood pressure reduction

Time frame: 4 month

Secondary Outcomes

Change in metabolic parameters Safety

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Boehringer Ingelheim Investigational Site 1

Aachen, Germany

Boehringer Ingelheim Investigational Site 2

Aachen, Germany

Boehringer Ingelheim Investigational Site 3

Aachen, Germany

Boehringer Ingelheim Investigational Site 4

Aachen, Germany

Boehringer Ingelheim Investigational Site 5

Aachen, Germany

Boehringer Ingelheim Investigational Site 6

Aachen, Germany

Boehringer Ingelheim Investigational Site 7

Aachen, Germany

Boehringer Ingelheim Investigational Site 8

Aachen, Germany

Boehringer Ingelheim Investigational Site

Aalen, Germany

Boehringer Ingelheim Investigational Site

Aarbergen, Germany

...and 2379 more locations